✦ LIBER ✦

Cost-effectiveness studies in ovarian cancer

✍ Scribed by T. D. Szucs; P. Wyss; K. J. Dedes

Book ID: 109085251
Publisher: John Wiley and Sons
Year: 2003
Tongue: English
Weight: 100 KB
Volume: 13
Category: Article
ISSN: 1048-891X
DOI: 10.1111/j.1525-1438.2003.13355.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Cost-Effectiveness Studies

✍ Chaiyakunapruk, N ;Saokaew, S ;Pansang, S 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 687 KB

Centralization of care for patients with

Centralization of care for patients with advanced-stage ovarian cancer : A cost-effectiveness analysis

✍ Robert E. Bristow; Antonio Santillan; Teresa P. Diaz-Montes; Ginger J. Gardner; 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 363 KB 👁 2 views

## Abstract ## BACKGROUND. The objective of this study was to evaluate the cost‐effectiveness of centralized referral of patients with advanced‐stage epithelial ovarian cancer who underwent primary cytoreductive surgery and adjuvant chemotherapy. ## METHODS. A decision‐analysis model was used to

Cost-effectiveness of lung cancer screen

Cost-effectiveness of lung cancer screening in Japan

✍ Naoyuki Okamoto 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 213 KB 👁 3 views

## BACKGROUND. Because the mortality rate from lung cancer is increasing sharply in Japan, lung cancer screening is being performed actively to assure early diagnosis and early treatment. However, its effectiveness is not clear, because it is extremely difficult to diagnose early microcarcinoma of

Cost-effectiveness and lung cancer clini

Cost-effectiveness and lung cancer clinical trials

✍ Wei Du; Jaxk H. Reeves; Shirish Gadgeel; Judith Abrams; William P. Peters 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 79 KB

## Abstract ## BACKGROUND Lung cancer is the leading cause of cancer death in the U.S., with an estimated annual economic burden of $5 billion. Clinical trials offer innovative therapeutic options with potentially better outcomes, but their effects on health care costs are disputed. ## METHODS T

Cervical-cancer screening: Attendance an

Cervical-cancer screening: Attendance and cost-effectiveness

✍ Marc A. Koopmanschap; Gerrit J. van Oortmarssen; Heleen M. A. van Agt; Marjolein 📂 Article 📅 1990 🏛 John Wiley and Sons 🌐 French ⚖ 769 KB

The influence of attendance on the health effects and costeffectiveness of cervical-cancer screening was studied, both for organized screening programmes and for spontaneous screening. The asymmetric distribution of smears among the female population and the higher risk incurred by women who never o

The cost-effectiveness of breast cancer

The cost-effectiveness of breast cancer screening

✍ Paul J. Van Der Maas; Harry J. De Koning; B. Martin Van Ineveld; Gerrit J. Van O 📂 Article 📅 1989 🏛 John Wiley and Sons 🌐 French ⚖ 728 KB

The costs and effects of different invitation schedules of breast cancer screening are compared. The effect estimates are based on trials from the USA, Sweden and the Netherlands. The cost estimates use registration data, file studies and organization charts. The calculations were performed with the